Achieve Life Sciences (ACHV) Intangibles (2016 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Intangibles of $696000.0 in Q1 2026, down 7.32% on a QoQ basis from $751000.0 in Q4 2025, and down 24.18% year-over-year from $918000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Intangibles (2016 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Intangibles across 11 years of filings, most recently posting $696000.0 for Q1 2026.
- Quarterly Intangibles fell 24.18% year-over-year to $696000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696000.0 (down 24.18% YoY) and the FY2025 annual result came in at $751000.0, down 22.9% from the prior year.
- Intangibles eased to $696000.0 in Q1 2026, from $751000.0 in the prior quarter.
- Over five years, Intangibles peaked at $1.6 million in Q1 2022 and troughed at $696000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Intangibles.
- Biggest YoY gain for Intangibles was 12.33% in 2022; the steepest drop was 50.91% in 2022.
- Tracing ACHV's Intangibles over 5 years: stood at $1.4 million in 2022, then dropped by 15.59% to $1.2 million in 2023, then decreased by 18.63% to $974000.0 in 2024, then decreased by 22.9% to $751000.0 in 2025, then fell by 7.32% to $696000.0 in 2026.
- Business Quant data shows ACHV's Intangibles at $696000.0 in Q1 2026, $751000.0 in Q4 2025, and $807000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 7.73 Mn |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | 696,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 696,000.00 |
| Dec 31, 2025 | 751,000.00 |
| Sep 30, 2025 | 807,000.00 |
| Jun 30, 2025 | 863,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 3.12 Mn |